Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling

BACKGROUND: To assess antivascular effects, and evaluate clinically translatable magnetic resonance imaging (MRI) biomarkers of tumour response in vivo, following treatment with vanucizumab, a bispecific human antibody against angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A)....

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Lauren CJ, Boult, Jessica KR, Thomas, Markus, Koehler, Astrid, Nayak, Tapan, Tessier, Jean, Ooi, Chia-Huey, Birzele, Fabian, Belousov, Anton, Zajac, Magdalena, Horn, Carsten, LeFave, Clare, Robinson, Simon P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023775/
https://www.ncbi.nlm.nih.gov/pubmed/27529514
http://dx.doi.org/10.1038/bjc.2016.236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023775/
https://www.ncbi.nlm.nih.gov/pubmed/27529514
http://dx.doi.org/10.1038/bjc.2016.236

Ejemplares similares